Biologics are an important and growing part of today's medicine.

Congress should allow biologics no more than five years of protection.

Nearly half of the 300 new drugs being developed for cancer are biologics.

Biologics are so complex that they can usually only be made by a living cell.

That is one reason companies like Lilly are moving into biologics.

The organization has completed its 20th first in human trial with biologics.

Like many new drugs, the biologics have high price tags.

Brand biologics are simply of no use to patients if they can't afford them.

New biologics are often among the more expensive medications on the market.

Biologics may increase the risk of minor and serious infections.

In severe cases, newer drugs called biologics may be used.

There is a wide range of known safety risks associated with biologics.

The issue is a concern for Lilly because about 70 percent of new products it has under development are biologics.

The safety of biologics during pregnancy has not been assessed.

Biologics are usually given by self-injection or in a doctor's office.

For those taking the new biologics, many questions remain.

Most biologics will start to lose their patent protection and be open to competition beginning in 2005.

This extra protection for biologics would add billions of dollars to future health care costs.

A 1984 law that set rules for other types of generic drugs did not address biologics.

The biologics were solely compared with placebo in nearly all of the studies.

It is another thing with biologics that are not only expensive but can have pretty significant side effects."

Access to biologics during an emergency may require special regulatory processes.

With higher risk biologics, each lot is tested before being released for sale in Canada.

But his interest seems to have turned to biologics after his retirement.

What is the long-term safety, by indication, of biologics? 2.